Enterprise Transformation at Pfizer Pharmaceutical Company

Running head: ENTERPRISE TRANSFORMATION
Enterprise transformation
Name of student
Name of University
Author note
Table of Contents

1ENTERPRISE TRANSFORMATION
Introduction......................................................................................................................................3
Organizational transformation.........................................................................................................3
Internal and external factors influencing the transformation of Pfizer pharmaceutical company...5
Conclusion.......................................................................................................................................7
References........................................................................................................................................8

2ENTERPRISE TRANSFORMATION
Introduction
The report is prepared to discuss about the process of transformation at Pfizer
pharmaceutical company in United States. The enterprise transformation process is enabled to
ensure that the organization’s functions strengthen and positive outcomes are achieved to gain
long term success in business. Pfizer pharmaceutical company is one of the major American
pharmaceutical conglomerate that has its headquarters in New York and its shares are major
components of the Dow Jones Industrial Average since the year 2004 until now. The medicines
and vaccines produced by the pharmaceutical company are used for various medical purposes
such as for neurology, oncology, cardiology and immunology (Pfizer.com 2018). The company’s
research and development facility has supported the development and production of various
medicines that are considered as effective for reducing the chances of rare type disease like
leukemia. Recently, the company has acquired Innopharma for $225 million for expanding its
wide range of medicines such as generic and injectable drugs, which has been the solution of
many critical diseases.
Organizational transformation
The transformation of Pfizer has occurred since 2009, which enabled numerous changes
adopted by the organization and with time, the company started to grow consistently. During the
last two years, the company has positioned itself well within the pharmaceutical industry and
established a sustainable place in the market. This not only helped in reaching different market
segments all over the world but also facilitated the research and development activities required
to manufacture and produce new vaccines and medicines that could be useful for treating types